Placental GH, IGF-I, IGF-binding protein-1 and leptin during a glucose challenge test in pregnant women : relation with maternal body weight, glucose tolerance, and birth weight
Verhaeghe, J.; Pintiaux, Axelle; Van Herck, E.et al.
2002 • In Journal of Clinical Endocrinology and Metabolism, 87 (6), p. 2875-2882
[en] The prediction of birth weight may be improved by the measurement of hormones or growth factors in the mother. We measured body weight (BW) and plasma levels of placental GH (PGH), IGF-I, IGF-binding protein-1 (IGFBP-1), and leptin at the time of the glucose challenge test (GCT) in 289 women, who were pregnant with a single fetus, between 24 and 29 wk gestational age (GA). Delivery occurred 12 +/- 2 (mean +/- SD) wk later. First, we examined which variables regulate these hormonal factors. Multiple regression showed that PGH concentrations were determined by GA at sampling and were negatively related to BW. IGF-I levels were mainly determined by PGH, and also by insulin, BW, and (negatively) age. IGFBP-1 concentrations were negatively determined by BW, insulin, and IGF-I. BW was also a powerful determinant of leptin levels, with insulin as a less robust determinant. Second, we examined the relation to glucose levels. PGH, IGF-I, and IGFBP-1 concentrations were not correlated with post-GCT glucose levels and were comparable in women with a normal or disturbed GCT (glucose >/=7.8 mmol/liter; n = 72). Finally, we examined the relation with birth weight and placental weight. Birth weight, corrected for GA and stratified into percentile groups, and the ponderal index at birth were strongly related to maternal BW, but not to maternal PGH, IGF-I, or IGFBP-1 levels. Neither was maternal leptin related to birth weight, but leptin concentrations were slightly higher in women who delivered obese babies. Placental weight was not related to any of the hormonal factors. This prospective study indicates that the variation in circulating PGH, IGF-I, IGFBP-1, and leptin between 24 and 29 wk of pregnancy is strongly dependent on maternal BW, but is unrelated to glucose tolerance. In addition, the measurement of PGH, IGF-I, IGFBP-1, or leptin at the time of the GCT is not useful clinically to predict birth weight.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Verhaeghe, J.
Pintiaux, Axelle ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Van Herck, E.
Hennen, Georges ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement
Igout, Ahmed ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Language :
English
Title :
Placental GH, IGF-I, IGF-binding protein-1 and leptin during a glucose challenge test in pregnant women : relation with maternal body weight, glucose tolerance, and birth weight
Publication date :
2002
Journal title :
Journal of Clinical Endocrinology and Metabolism
ISSN :
0021-972X
eISSN :
1945-7197
Publisher :
Endocrine Society, Chevy Chase, United States - Maryland
Jovanovic L. (2000) A tincture of time does not turn the tide. Type 2 diabetes trends in offspring of type 2 diabetic mothers. Diabetes Care 23:1219-1220.
Caufriez A., Frankenne F., Englert Y., Golstein J., Cantraine F., Hennen G., Copinschi G. (1990) Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 258.
Mirlesse V., Frankenne F., Alsat E., Poncelet M., Hennen G., Evain-Brion D. (1993) Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res 34:439-442.
Rutanen E.-M., Bohn H., Seppälä M. (1982) Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol 144:460-463.
Wang H.S., Perry L.A., Kanisius J., Iles R.K., Holly J.M.P., Chard T. (1991) Purification and assay of insulin-like growth factor-binding protein-1: Measurement of circulating levels throughout pregnancy. J Endocrinol 128:161-168.
Lee P.D.K., Giudice L.C., Conover C.A., Powell D.R. (1997) Insulin-like growth factor binding protein-1: Recent findings and new directions. Proc Soc Exp Biol Med 216:319-357.
Sattar N., Greer I.A., Pirwani I., Gibson J., Wallace A.M. (1998) Leptm levels in pregnancy: Marker for fat accumulation and mobilization?. Acta Obstet Gynecol Scand 77:278-283.
Linnemann K., Malek A., Sager R., Blum W.F., Schneider H., Fusch C. (2000) Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab 85:4298-4301.
Caufriez A., Frankenne F., Hennen G., Copinschi G. (1993) Regulation of maternal IGF-I by placental GH in normal and abnormal pregnancies. Am J Physiol 265.
Larsen T., Main K., Andersson A.M., Juul A., Greisen G., Skakkebaek N.E. (1996) Growth hormone, insulin-like growth factor I and its binding proteins 1 and 3 in last trimester intrauterine growth retardation with increased pulsatility index in the umbilical artery. Clin Endocrinol (Oxf) 45:315-319.
Holmes R.P., Holly J.M.P., Soothill P.W. (1998) A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses. Br J Obstet Gynaecol 105:1273-1278.
Fowler D., Albaiges G., Lees C., Jones J., Nicolaldes K., Miell J. (1999) The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by Doppler ultrasound. Hum Reprod 14:2881-2885.
McIntyre H.D., Serek R., Crane D.I., Veveris-Lowe T., Parry A., Johnson S., Leung K.C., Ho K.K., Bougoussa M., Hennen G., Igout A., Chan F.Y., Cowley D., Cotterill A., Barnard R. (2000) Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: Correlations with fetal growth. J Clin Endocrinol Metab 85:1143-1150.
Baldwin S., Chung T., Rogers M., Chard T., Wang H.S. (1993) Insulin-like growth factor-binding protein-1, glucose tolerance and fetal growth in human pregnancy. J Endocrinol 136:319-325.
Hills F.A., English J., Chard T. (1996) Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: Relation to birthweight and maternal weight. J Endocrinol 148:303-309.
Gibson J.M., Westwood M., Lauszus F.F., Klebe J.G., Flyvbjerg A., White A. (1999) Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects. Diabetes 48:321-326.
Scholl T.O., Stein T.P., Smith W.K. (2000) Leptin and maternal growth during adolescent pregnancy. Am J Clin Nutr 72:1542-1547.
Kautzky-Willer A., Pacini G., Tura A., Bieglmayer C., Schneider B., Ludvik B., Prager R., Waldhäusl W. (2001) Increased plasma leptin in gestational diabetes. Diabetologia 44:164-172.
Wheeler T., Chard T., Anthony F., Osmond C. (1995) Relationships between the uterine environment and maternal plasma concentrations of insulin-like growth factor binding protein-1 and placental protein 14 in early pregnancy. Hum Reprod 10:2700-2704.
Garn S.M., Pesick S.D. (1982) Relationship between various maternal body mass measurements and size of the newborn. Am J Clin Nutr 36:664-668.
(2000) Clinical practice recommendations 2000. Diabetes Care 23(SUPPL. 1).
Freinkel N. (1980) Of pregnancy and progeny. Diabetes 29:1023-1035.
Hansen I., Tsalikian E., Beaufrere B., Gerich J., Haymond M., Rizza R. (1986) Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action. Am J Physiol 250.
Rizza R.A., Mandarino L.J., Gerich J.E. (1982) Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669.
Patel N., Alsat E., Igout A., Baron F., Hennen G., Porquet D., Evain-Brion D. (1995) Glucose inhibits placental GH secretion in vitro. J Clin Endocrinol Metab 80:1743-1746.
Crossey P.A., Jones J.S., Miell J.P. (2000) Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 49:457-465.
Davey D.A., MacGillivray I. (1988) The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892-898.
Devlieger H., Martens G., Bekaert A., Eeckels R. (2000) Standaarden van geboortegewicht-voor-zwangerschapsduur voor de Vlaamse boreling. Tijdschr Geneesk 56:1-14.
Lockwood C.J., Weiner S. (1986) Assessment of fetal growth. Clin Perinatol 13:3-35.
Yalow R.S., Berson S.A. (1960) Immunoassay of endogenous plasma insulin in man. J Clin Invest 39:1157-1175.
Igout A., Van Beeumen J., Frankenne F., Scippo M.-L., Devreese B., Hennen G. (1993) Purification and biochemical characterization of recombinant human placental growth hormone produced in Escherichia coli. Biochem J 295:719-724.
Igout A., Hennen G. (1997) The human placental growth hormone variant: A review. Trophoblast Res 10:345-352.
Verhaeghe J., Bougoussa M., Van Herck E., De Zegher F., Hennen G., Igout A. (2000) Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency. Clin Endocrinol (Oxf) 53:645-647.
Bouillon R., Bex M., Van Herck E., Laureys J., Dooms L., Lesaffre E., Ravussin E. (1995) Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80:1194-1202.
Verhaeghe J., Coopmans W., Van Herck E., Van Schoubroeck D., Deprest J.A., Witters I. (1999) IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth. Pediatr Res 46:101-108.
Bekaert A., Martens G., Devlieger H., Amy J.J., Defoort P., Cammu H. Perinatale activiteiten in Vlaanderen 1999, Studiecentrum voor Perinatale Epidemiologie, Brussel; 2000.
Sermer M., Naylor D., Gare D.J., Kenshole A.B., Ritchie J.W., Farine D., Cohen H.R., McArthur K., Holzapfel S., Biringer A., Chen E., Cadesky K.I., Greenblatt E.M., Leyland N.A., Morris H.S., Bloom J.A., Abells Y.B. (1994) Impact of time since last meal on the gestational glucose challenge test. Am J Obstet Gynecol , The Toronto Tri-Hospital Gestational Diabetes Project; 171:607-616.
Veldhuis J.D., Iranmanesh A., Ho K.K.Y., Waters M.J., Johnson M.L., Lizarralde G. (1991) Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59.
Coutant R., Boux de Casson F., Douay O., Mathieu E., Rouleau S., Beringue F., Gillard P., Limal J.M., Descamps P. (2001) Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: Implications for birth weight. J Clin Endocrinol Metab 86:4854-4859.
Rutanen E.-M., Seppälä M., Pietilä R., Bohn H. (1984) Placental protein 12 (PP12): Factors affecting levels in late pregnancy. Placenta 5:243-248.
Hu M., Robertson D.G., Murphy L.J. (1996) Growth hormone modulates insulin regulation of hepatic insulin-like growth factor binding protein-1 transcription. Endocrinology 137:3702-3709.
Licinio J., Negrão A.B., Mantzoros C., Kaklamani V., Wong M.L., Bongiorno P.B., Mulla A., Cearnal L., Veldhuis J.D., Flier J.S., McCann S.M., Gold P.W. (1998) Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci USA 95:2541-2546.
Mantzoros C.S., Liolios A.D., Tritos N.A., Kaklamani V.G., Doulgerakis D.E., Griveas I., Moses A.C., Flier J.S. (1998) Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men. Obes Res 6:179-186.
Ruige J.B., Dekker J.M., Blum W.F., Stehouwer C.D., Nijpels G., Mooy J., Kostense P.J., Bouter L.M., Heine R.J. (1999) Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn study. Diabetes Care 22:1097-1104.
Doucet E., St-Pierre S., Alméras N., Mauriege P., Despres J.P., Richard D., Bouchard C., Tremblay A. (2000) Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: Evidence from both a cross-sectional and an intervention study. J Clin Endocrinol Metab 85:4231-4237.
